Characterization and regulation of wild‐type and mutant TASK‐1 two pore domain potassium channels indicated in pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Characterization and regulation of wild‐type and mutant TASK‐1 two pore domain potassium channels indicated in pulmonary arterial hypertension

Published:2018-11-24 Issue:4 Volume:597 Page:1087-1101
ISSN:0022-3751
Container-title:The Journal of Physiology
language:en
Short-container-title:J Physiol

Author:

Cunningham Kevin P.¹^ORCID,Holden Robyn G.¹,Escribano‐Subias Pilar M.²,Cogolludo Angel³⁴^ORCID,Veale Emma L.¹,Mathie Alistair¹^ORCID

Affiliation:

1. Medway School of PharmacyUniversity of Kent and University of Greenwich Chatham Maritime Kent UK

2. Red de Investigación CardiovascularInstituto de Salud Carlos III Madrid Spain

3. Department of Pharmacology and ToxicologySchool of MedicineUniversity Complutense of MadridInstituto de Investigación Sanitaria Gregorio Marañón (IiSGM) Madrid Spain

4. Ciber Enfermedades Respiratorias (CIBERES) Madrid Spain

Funder

University of Kent

Biotechnology and Biological Sciences Research Council

Publisher

Wiley

Subject

Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1113/JP277275

Reference49 articles.

1. Modifying the Subunit Composition of TASK Channels Alters the Modulation of a Leak Conductance in Cerebellar Granule Neurons

2. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension

3. Motoneurons Express Heteromeric TWIK-Related Acid-Sensitive K+ (TASK) Channels Containing TASK-1 (KCNK3) and TASK-3 (KCNK9) Subunits

4. The Impact of Heterozygous KCNK3 Mutations Associated With Pulmonary Arterial Hypertension on Channel Function and Pharmacological Recovery

5. Potassium channels in pulmonary arterial hypertension

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Contribution of Genetic Sequencing Information to the Identification and Functional Characterization of Two-Pore Domain Potassium (K2P) Channels as Viable Therapeutic Targets;Ion Channels as Targets in Drug Discovery;2024

2. Therapeutic Targeting of Potassium Channels;Ion Channels as Targets in Drug Discovery;2024

3. Defining the clinical validity of genes reported to cause pulmonary arterial hypertension;Genetics in Medicine;2023-11

4. Hypoxia and panvascular diseases: exploring the role of hypoxia-inducible factors in vascular smooth muscle cells under panvascular pathologies;Science Bulletin;2023-09

5. Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart;The Journal of Physiology;2023-07-21